1/94
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Urolithiasis-patho
development of renal calculi
C+ most common component
urolithiasis-etiology
urinary stasis
elevated urinary levels of salt, organic/inorganic acids
urolithiasis-risk factors
genetics
UTI
cystic kidney disease
diabetes
obesity
gout, hyperparathyroidism
gastric bypass
urolithiasis-clinical manifestations
pain
colic
distention of collecting systems or ureter
acute, intermittent, radiating, excruciating
noncolic
distention of renal calices or pelvis
dull, deep with varying intensity
urolithiasis-diagnosis
subjective findings
history of pain
imaging
CT
renal ultrasound
Lab analysis
urinalysis
analysis of calculi composition
urolithiasis-treatment
supportive treatment
pharm
analgesics
antispasmodic agents
calcium channel blockers, alpha blockers
fluids
calculi removal
inc. fluid intake
reduction in calculi size
surgical
prevention
diet low in calcium oxolate
adequate fluid intake
alkalinization of urine
urolithiasis-food to avoid
beets
chocolate
coffee
coke
nuts
wheat
urinary incontinence-patho
inability to voluntary prevent the discharge of urine
urinary incontinence-etiology
impaired muscle contraction
altered neural transmission
hormonal stimulation
mechanical factors
female: relax of pelvic structure
male: mechanical obstruction by prostate
urinary incontinence-clinical manifestation
determined by classification
stress incontinence
external stimulus
urge incontinence
overactivity of detrusor muscle; have to go
overflow incontinence
exceeding bladder capacity
functional incontinence
inability to independently toilet
urinary incontinence-diagnosis
H&P of patterns and triggers
specialized test
bladder tress test
post residual bladder volume
urodynamic testing(gold standard)
cytometry, cystometrogram, voiding cystometrogram
endoscopic testing
cystoscopy
urinary incontinence-treatment
behavioral strategies
bladder training
pelvic floor strenghthening (kegel exercise)
pharm
anticholinergic meds
alpha adrenergic meds
surgical
support urethra
relief of mechanical obstruction from an enlarged prostate
polycystic kidney disease(PKD)-patho
growth of fluid filled cyst bilaterally in kidneys
functional tissue replaced
reduced perfusion
tubule obstruction
categories:
genetic, autosomal dominant or recessive
acquired
PKD-clinical manifestations
enlarged kidneys
flank pain
nausea, anorexia
hypertension
liver and pancreatic cyst
renal calculi
diverticular disease
PKD-diagnosis
family hystory
genetic testing
Physical→ hypertention
imaging
presence of >3 or more kidney cyst on ultrasound
estrarenal cyst
lab confirmation of renal failure
GFR, BUN, Cr
PKD-treatment
symptomatic care
pain control
treatment of infection
BP control
Lifestyle modifications
promotion of renal function
dialysis
special filters, heparin, wastes and excess water removed by peritoneal membrane, exchange of solution and wastes
renal transplant → severe cases
diverticular-patho
prolong pressure on large intestine walls alters structure and function
weakness leads to outpouching
GI consequences
decreased motility
obstruction
impaired perfusion
diverticulum along the wall of colon
small sac; outpouching
diverticula
more than one diverticulum
diverticulosis
prescense of diverticula
diverticulosis
diverticula infected due to fecal matter
diverticular- clinical manifestations
abdominal pain
fever
N&V
diverticular-diagnosis
H&P
abdominal tenderness
distention
lab analysis
bloody stools
low hemoglobin and hematocrit → anemia
CBS → infection
imaging studies
inflamed and/or ruptured diverticuli
diverticular-treatment
management of symptoms
control of infection
bowel rest
prevention of complications
surgical correction of perforated diverticula
bowel resection
colostomy
diverticular-prevention
dietary alterations
lifestyle alterations
meds
bulk-forming laxatives
antispasmodics
Lung cancer-patho
leading cause of cancer deaths
smoking and industrial exposures often implicated
tumors most frequently originate in epithelial lining of the bronchi, bronchioles, and alveoli
4 subtypes
adenocarcinoma(most common), squamous cells, large cell, and small cell carcinoma
lung cancer-clinical manifestations
persistent cough
hemoptysis(bloody sputum)
chest pain
shortness of breath
lung cancer-diagnosis
H&P exam
Bronchoscopy
chest x-ray
CBC(high early on and low later on)
tissue biopsy/cytology
Lung cancer-treatment
based on tumor type
small cell carcinoma
chemo
non-small cell carcinoma
surgery
chemo
radiation, when surgery not feasible
colon cancer-patho
proliferation abnormality in colon
common tumors
nonneoplastic polyp
neoplastic polyps
adenocarcinomas
mutation pathways
chromosomal instability
replication errors
affinity to go to liver
colon cancer-risk factors
age
family history
smoking
alcohol
bowel disease
obesity
high-fat diet
colon cancer-clinical manifestations
change in bowel habits
occult/frank blood in stool
abdominal pain
bowel obstruction
anemia
colon cancer-diagnosis
CBC→ anemia
liver function test (affinity to liver)
CEA high
colonoscopy
sigmoidoscopy
biopsy of suspicious lesions
colon cancer-treatment
surgery
chemo
biology agents
radiation
brain cancer-patho
metastasis much more common to brain than primary tumor
primary tumors:
gliomas
meningiomas
pituitary adenomas
acoustic neuromas
brain cancer-clinical manifestations
loss of motor or sensory function
cognitive or behavioral changes
headache
vomiting
seizures
brain cancer-diagnosis
neurological exam
CN
reflexes
sensory function
motor function
direct visualization
brain scan
x-ray
CT/MRI
cerebral angiography
PET scan
brain cancer-treatment
surgery(common)
radiation(common)
chemo
palliative care(when nothing can be done)
Leukemia-patho
Malignant neoplasms of blood and blood-forming organs
overproliferation of WBC
immature WBC
acute
lymphocytic(ALL); most common in children
myeloid(AML); most common in adults
rapid, onset, more life threatning
chronic
lymphocytic(CLL)
myelogenous(CML)
can be asymptomatic
leukemia-clinical manifestation
anemia
bruising
fatigue
headache
visual disturbances
N&V
weight loss
fever
lymph node and organ enlargement
leukemia-diagnosis
H&P exam
CBC
bone marrow biopsy
cytologic exam of blood cells
leukemia-treatment
chemo
radiation
bone marrow or stem cell transplant
lymphoma-patho
derived from WBCs and lymph tissues that form solid organ tumors in the lymph tissue and later in bone marrow
classified:
Hodgkin lymphoma
Non-Hodgkin lymphoma
lymphoma-clinical manifestations
hodgkin
painless, progressive enlargement of cervical lymph nodes
low-grade fever, night sweats, weight loss, fatigue
non-hodgkin
painless enlargement of lymph nodes
systemic manifestations may also occur
lymphoma-diagnosis
hodgkin
presence of Reed-Sternberg cells
non-hodgkin
H&P exam
lymph node biopsy
chest and abdominal CT scan
lymphoma-treatment
hodgkin
chemo
radiation
hematopoietic( production of new blood) stem cell transplant
non-hodgkin
radiation
chemo(aggressive forms)
Hypertention-patho
>130/80
progressive cardiovascular syndrome by an elevated in BP and/or prescence of organ damage due to persistent BP elevations
primary (sometimes no cause) vs secondary (identifiable causes: kidney disease, endocrine disease, renal artery stenosis)
hypertension-risk factors
family history
aging
black race
decreased nephron count
diabetes mellitus
excessive Na+ intake
obesity
sedentary lifestyle
smoking
excessive alcohol
hypertension-clinical manifestations
asymptomatic w/ primary(essential)
when advanced:
headache
new-onset blurred vision
N&V
weakness
fatigue
mental status change
cardiovascular change:
pulmonary edema and HR
renal insufficiency:
poor urinary output
problems w/ elimination
hematuria
proteinuria
hypertension-diagnosis
H&P
serial BP measurements
Lab studies
classification:
elevated: 120-129/less than 80
stage 1: 130-139/80-89
stage 2: 140-higher/ 90- higher
hypertension- treatment
pharm
lifestyle changes
weight reduction
decreased alcohol, salt, saturated fat
increased aerobic physical activity
inc. fruit and veg intake
smoking cessation
shock-patho
circulatory failure and impaired perfusion of vital organs
sources of impaired perfusion:
ineffective cardiac pumping: cardiogenic shock
decreased blood volume: hypovolemic shock
massive systemic vasodilation
severe infection: septic shock
brain or spinal cord injury: neurogenic shock
IgE mediated allergic reaction: anaphylactic shock
shock-clinical manifestations
tachycardia, tachypnea
cool, clammy extremities; peripheral pulses
decreased arterial BP
cyanosis and/or pallor
restlessness, apprehension, decreased mental function
poor urinary output
advance metabolic acidosis
shock-diagnosis
no one test to completely diagnose
H&P exam
Lab studies:
renal-creatine & BUN
WBC
lactic acid
ABG
diagnostic testing
BP(inc)
Resp rate
Temp
Icr BP and WBC will lead to shock
shock-treatment
medical emergency
ABCs
treatment depends on type
cardiogenic
hypovolemic
septic
neurogenic
anaphylactic
myocardial infarction-patho
total occlusion of 1 or more coronary arteries → ischemia and death of tissue
atherosclerosis is most common cause
blood flow reduced
STEMI
note leads of elevation (ST elevation)
Non STEMI
in women and older ppl
MI -risk factors
family history of CAD
hypertension and smoking
blood cholesterol levels
concurrent diabetes mellitus
high-sensitivity C-reactive protein(CRP)
hyperhomocysteinemia
MI-clinical manifestation
gender variability
chest pain or crushing pressure; often radiating to L arm, shoulder, or jaw
fatigue, weakness, syncope(fainting), anxiety
dizziness, SOB(dyspnea)
sweating, pallor
indigestion
N&V
MI-diagnosis
H&P exam
Lab studies( cardiac enzymes)
tropinin →ischemia
CKMB→ infraction
ECG
angiography
echocardiography
chest radiograph
MI-treatment
emergency management
medical: ABCs
Morphine,O2,Nitro,Aspirin
surgical
PCI, PTCA
long-term treatment
pharm
antiplatelet, anticoagulant, beta, ACE inhibitor, statins
lifestyle modifications
heart failure-patho
inadequate heart pumping→ fails to maintain circulation of blood
result of:
impaired cardiac functioning
excessive workload demand
L heart failure(lung problrm)
L ventrical cant pump to systemic ventilation
R heart failure(systemic problem):
back up in systemic
comes from untreated L heart failure
LHF-clinical manifestations
activity intolerance and signs of decreased tissue perfussion
cyanosis, hypoxia
cough w/ frothy sputum, crackles
orthopnea(SOB when laying)
paroxysmal nocturnal dyspnea(severe SOB at night when sleeping that makes you cough)
RHF-clinical manifestations
edema and ascites
anorexia, GI distress, weight loss
signs related to impaired liver function
peripheral edema
HR-diagnosis
H&P exam
chest radiography
echocardiography
ECG
cardiac catheterization
HF-treatment
goals
correct cause
improve cardiac output
reduce peripheral vascular resistance
improve quality of life
treatment
pharm(diuretics)
surgery
treat underlying cause
supplement O2
lifestyle modifications
smoking cessation
stroke-patho
any clinical event that leads to impaired cerebral circulation
thrombotic, embolic, hemorrhagic
inflammation, ischemia, death of neurons
cerebrovascular accident(CVA) vs transient, ischemic attack (TIA)
stroke-clinical manifestations
focal brain injury
abrupt onset of hemiparesis
vision loss or field deficits
dizziness, diplopia
ataxia, aphasia
sudden decrease in level of consciousness
stroke-diagnosis
H&P exam
Lab studies
CT scan (see if intracranial bleeding)
no blood→ ischemic
blood→ hemorrhatic
stroke-treatment
emergency management
reduce cerebral edema and increased intracranial pressure
TPA given for ischemic
rehabilitation
disseminated intravascular coagulation(DIC)-patho
complication from other disease
uncontrolled activation of clotting factors
widespread thrombi formation→ depletion of coagulation factors and platelets leading to massive hemorrhage
initiated by endothelial injury
blood transfusion injury
DIC-clinical manifestation
excessive hemorrhage
epistaxis(nosebleed)
bruising
excessive clotting
headache
weakness
seizures, coma
renal
poor urine output
renal failure
respiratory
cough
SOB
chest pain
resp distress
DIC-diagnosis
H&P exam
lab testing
prothrombin time (PT)
activated partial thromboplastin time (aPTT)
platelet count low
fibrinogen level*
D-timer test(confirmatory)*
DIC-treatment
correct underlying cause
depends on presence of hemorrhage vs thromboses
balance goal of proper coagulation
platelet , blood, and plasma transfusion